Curtis Lockshin
Directeur/Membre du Conseil chez PHIO PHARMACEUTICALS CORP.
Fortune : 2 214 $ au 30/06/2024
Profil
Curtis A.
Lockshin is currently the Director at Ruth K.
Broad Biomedical Research Foundation, Inc. since 2004 and the Independent Director at Phio Pharmaceuticals Corp.
since 2013.
He previously served as the President & Chief Executive Officer at Guardum Pharmaceuticals LLC.
He was also the Chief Executive Officer & Director at SciVac Ltd.
from 2014 to 2016 and at SciVac Therapeutics, Inc. from 2015 to 2016.
Dr. Lockshin held the position of Director-Discovery Biology & Informatics at Sumitomo Pharma America, Inc. from 1998 to 2002.
He has also worked as a Director at clickNsettle.com, Inc. in 2007-2008, Orthodontix, Inc. in 2006, Getting Ready Corp.
in 2006-2008, BG Medicine, Inc. in 2002-2003, Quikbyte Software, Inc. in 2008-2009, Chromadex Corp.
as an Independent Non-Executive Director from 2011 to 2014, Winston Pharmaceuticals, Inc. as a Director from 2008 to 2010, Sorrento Therapeutics, Inc. as an Independent Director from 2008 to 2012, Tiger X Medical, Inc. as a Director, Xenetic Biosciences (UK) Ltd.
as the Vice President-Research & Operations from 2014 to 2017, OPKO Health, Inc. as the Vice President-Research & Development Initiatives from 2011 to 2013, VBI Vaccines, Inc. as the Chief Technical Officer in 2016, and Xenetic Biosciences, Inc. as the Chief Scientific Officer from 2017 to 2024.
Dr. Lockshin obtained his undergraduate and doctorate degrees from the Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/04/2024 | 3 200 ( 0,07% ) | 2 214 $ | 30/06/2024 | |
| 11/12/2023 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Curtis Lockshin
| Sociétés | Poste | Début |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Directeur/Membre du Conseil | 18/04/2013 |
| Ruth K. Broad Biomedical Research Foundation, Inc. | Directeur/Membre du Conseil | 01/04/2004 |
Anciens postes connus de Curtis Lockshin
| Sociétés | Poste | Fin |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Directeur des opérations | 06/12/2016 |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Directeur des opérations | 01/01/2017 |
| VBI VACCINES INC. | Directeur Technique/Scientifique/R&D | 22/12/2016 |
| SciVac Therapeutics, Inc. | Directeur Général | 01/07/2016 |
| CHROMADEX CORPORATION | Directeur/Membre du Conseil | 03/01/2014 |
Formation de Curtis Lockshin
| Massachusetts Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| BG MEDICINE, INC. | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| CHROMADEX CORPORATION | Health Technology |
| WINSTON PHARMACEUTICALS, INC. | Health Technology |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| XENETIC BIOSCIENCES, INC. | Health Technology |
| VBI VACCINES INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
clickNsettle.com, Inc.
 clickNsettle.com, Inc. Internet Software/ServicesTechnology Services The Company's principal activity is to seek a new operating business or enter into a merger transaction. Previously the Company provided arbitration and mediation services, also known as alternative dispute resolution services (ADR) and related electronic oversight applications. In addition, the Company offered advisory opinions, mock jury trials and other specialized dispute resolution programs depending on the parties' particular needs. Currently the Company does not operate any business. | Technology Services |
| Orthodontix, Inc. | Finance |
Getting Ready Corp.
 Getting Ready Corp. Financial ConglomeratesFinance The Company intends to open Mother Supercare Centers in target areas across the United States. The Mother Supercare Centers will offer prenatal, childbirth, postpartum and parenting services to women and their families. These services will be provided through education, counseling, support services and products for women and infants that promote a healthy pregnancy, birth, postpartum and early parenting period. The Group is a development Stage Company. | Finance |
Quikbyte Software, Inc.
 Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL. | Finance |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Tiger X Medical, Inc.
 Tiger X Medical, Inc. Medical SpecialtiesHealth Technology Tiger X Medical, Inc. engages in the collection and management of royalty income earned in connection with the Asset Purchase Agreement with Arthrex, Inc. It continue to advance and promote its former knee product lines through participation in mobile teaching labs, seminars, and live surgery. Its also evaluates future investment opportunities and uses for its cash. The company was founded by Andrew A. Brooks on April 6, 2007 and is headquartered in Los Angeles, CA. | Health Technology |
| Ruth K. Broad Biomedical Research Foundation, Inc. | |
Guardum Pharmaceuticals LLC
 Guardum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Guardum Pharmaceuticals LLC produces pharmaceutical preparations. The company is based in Miami, FL. Guardum Pharmaceuticals was acquired by Pharmsynthez PJSC on April 18, 2013. | Health Technology |
SciVac Ltd.
 SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Health Technology |
| SciVac Therapeutics, Inc. | Health Technology |
